SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.12 CNY | +1.90% |
|
+1.73% | -3.64% |
| Apr. 30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
| Apr. 29 | Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 43.61B 6.04B | Sales 2025 * | 48.64B 6.74B | Capitalization | 57.63B 7.99B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.21B 445M | Net income 2025 * | 3.93B 544M | EV / Sales 2024 * | 1.68 x |
| Net Debt 2024 * | 15.46B 2.14B | Net Debt 2025 * | 17.72B 2.46B | EV / Sales 2025 * | 1.55 x |
| P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
15.5
x | Employees | 40,370 |
| Yield 2024 * |
1.55% | Yield 2025 * |
2% | Free-Float | 63.46% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.90% | ||
| 1 week | +1.73% | ||
| Current month | +1.90% | ||
| 1 month | +3.34% | ||
| 3 months | +4.19% | ||
| 6 months | -16.31% | ||
| Current year | -3.64% |
1 week
23.82
24.20
1 month
22.2524.20
Current year
20.3825.89
1 year
20.3832.73
3 years
20.3891.69
5 years
20.3891.69
10 years
16.5091.69
| Managers | Title | Age | Since |
|---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Dong Ming Li
PSD | President | 55 | 20-10-28 |
Yi Fang Wu
CHM | Chairman | 54 | 04-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-04-08 |
Qi Yu Chen
BRD | Director/Board Member | 52 | 94-03-31 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.27% | 2 M€ | -12.87% | - | |
| 1.18% | 4 M€ | -2.96% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 24.12 | +1.90% | 13,530,900 |
| 24-04-30 | 23.67 | -0.17% | 9,600,485 |
End-of-day quote Shanghai S.E., May 05, 2024
More quotes
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
24.12
CNY
Average target price
28.61
CNY
Spread / Average Target
+18.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.64% | 8B | |
| +31.52% | 690B | |
| +24.18% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +14.00% | 235B | |
| +5.00% | 199B | |
| -10.22% | 195B | |
| +3.98% | 161B |
- Stock Market
- Equities
- 600196 Stock